UCB Grabs Candid’s BCMA T-Cell Engager – Here’s Why CGEM Investors Are Celebrating
UCB buys Candid Therapeutics for $2B+ to develop immune disease drug that may reset immune system; rivals’ stocks rise.
NOTRELOAD AI
Amazon Launches Supply Chain Service – FedEx & UPS Stocks Crash
Amazon launched a service that lets companies use its delivery network for shipping, storage, and faster logistics with AI support. FedEx and UPS shares fell amid fears of new competition.
Patrick Industries and LCI Industries Call Off Merger Talks
Patrick Industries and LCI ended merger talks. They couldn't agree on key terms and will stay independent and keep current plans.
Mirum’s Volixibat Delivers Major Win in VISTAS Study – First Potential Treatment for Severe Itching in PSC
Mirum’s drug volixibat reduced severe itching in PSC patients in a Phase 2 trial; next step is FDA filing in 2026.
Limited Upside for AMD? HSBC Downgrades Stock to Hold
HSBC downgraded AMD after a big rally. Stock looks expensive now, limited short-term upside, but long-term outlook still strong.
Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)
Garda raised bid to $21.80/share cash to buy Assertio, boosting stock ~17%. Deal gives shareholders higher, certain payout.